Ergoteles’s Apyx Medical APYX Stock Holding History

Ergoteles’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-41,866	Closed	-$188K	–	1431
2022 Q3	$188K	Sell	41,866 -118,970	-74%	-$852K	0.01%	1203
2022 Q2	$942K	Buy	+160,836	New	+$825K	0.03%	569
2021 Q3	–	Sell	-10,000	Closed	-$103K	–	1185
2021 Q2	$103K	Buy	+10,000	New	+$99.1K	﹤0.01%	1410

Other funds holding APYX

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ergoteles's APYX Position: Q4 2022 in Review

Ergoteles sold out of Apyx Medical (APYX) in Q4 2022, closing a stake of 41,866 shares — an estimated $188K sold.

Ergoteles first reported a position in APYX in Q2 2021 and held it in 3 quarters. The position peaked at $942K in Q2 2022. 50 funds tracked by Wall St. Rank hold APYX as of Q4 2022.

Ergoteles reported no remaining Apyx Medical position as of Q4 2022 after selling out during the quarter.
Ergoteles sold 41,866 Apyx Medical shares in Q4 2022, an estimated $188K.
Ergoteles first reported a position in Apyx Medical in Q2 2021 and held it in 3 quarters.
Ergoteles's Apyx Medical position peaked at $942K in Q2 2022.
50 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.